P1454: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) IN THE UNITED STATES (US)
F. Locke, MD,
Z.-H. Hu, MPH,
J. Gerson, MD,
M. J. Frank, PhD,
L. E. Budde, PhD,
M. Wang, MD,
B. Logan, PhD,
I. Kloos, PhD,
R. Siddiqi, PhD,
J. Shah, MD,
H. Xu, PhD,
M. Pasquini, MS
Affiliations
F. Locke, MD
1 H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Z.-H. Hu, MPH
2 Kite, a Gilead company, Santa Monica, CA
J. Gerson, MD
3 University of Pennsylvania, Philadelphia, PA
M. J. Frank, PhD
L. E. Budde, PhD
M. Wang, MD
6 The University of Texas MD Anderson Cancer Center, Houston, TX
B. Logan, PhD
7 Medical College of Wisconsin, Milwaukee, WI, United States of America
